Human glandular kallikrein in breast milk, amniotic fluid, and breast cyst fluid

Clinical Chemistry

Volumn 45, Issue 10, 1999, Pages 1774-1780

  Magklara, Angeliki ^a,b   Scorilas, Andreas ^a,b   Löpez Otín, Carlos ^c   Vizoso, Francisco ^d   Ruibal, Alvaro ^e   Diamandis, Eleftherios P ^a,b  

^a MOUNT SINAI HOSPITAL   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF OVIEDO   (Spain)

^d HOSPITAL DE JOVE   (Spain)

^e Fundacion Tejerina   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

KALLIKREIN; PROSTATE SPECIFIC ANTIGEN; SERINE PROTEINASE;

AMNION FLUID ANALYSIS; ARTICLE; BREAST CYST; BREAST MILK; DIAGNOSTIC VALUE; DISEASE MARKER; ENZYME SYNTHESIS; FEMALE; HUMAN; IMMUNOASSAY; MILK LEVEL; PROTEIN DEGRADATION; SEQUENCE HOMOLOGY;

EID: 0032832599     PISSN: 00099147     EISSN: None     Source Type: Journal    
DOI: 10.1093/clinchem/45.10.1774     Document Type: Article

References (43)

1. 1. Clements JA. Current perspectives on the molecular biology of the renal tissue kallikrein gene and the related tissue kallikrein gene family [Review]. Biol Res 1998;31:151-9.
2. 2. Berg T, Bradshaw RA, Carretero OA, Chao J, Chao L, Clements JA, et al. A common nomenclature for members of the tissue (glandular) kallikrein gene families. Agents Actions Suppl 1992:38:19-25.
3. 3. Ban Y, Wang MC, Watt KW, Loor R, Chu TM. The proteolytic activity of human prostate-specific antigen. Biochem Biophys Res Commun 1984;123:482-8.
4. 4. Papsidero L, Kuriyama M, Wang MC, Horoszewicz J, Leong SS, Valenzuela L, et al. Prostate antigen: a marker for human prostate epithelial cells. J Natl Cancer Inst 1981:66:37-42.
5. 5. Aumüller G, Seitz J, Lilja H, Abrahamsson PA, von der Kammer H, Scheit KH. Species- and organ-specificity of secretory proteins derived from human prostate and seminal vesicles. Prostate 1990;17:31-40.
6. 6. Diamandis EP. Prostate specific antigen - its usefulness in clinical medicine [Review]. Trends Endocrinol Metab 1998;9:310-6.
7. 7. Diamandis EP, Yu H. New biological functions of prostate specific antigen? J Clin Endocrinol Metab 1995;80:1515-7.
8. 8. Diamandis EP, Yu H. Non-prostatic sources of prostate-specific antigen. In: Oesterling JE, ed. Prostate-specific antigen: the best prostatic tumor marker. The Urologic Clinics of North America, Vol. 24. Philadelphia, PA: WB Saunders, 1997:275-82.
9. 9. Frazer HA, Humphrey PA, Burchette JL, Paulson DF. Immunoreactive prostatic specific antigen in male periurethral glands. J Urol 1992:147:246-8.
10. 10. Iwakiri J, Granbois K, Wehner N, Graves HCB, Stamey T. An analysis of urinary prostatic specific antigen before and after radical prostatectomy: evidence for secretion of prostatic specific antigen by the periurethral glands. J Urol 1993:149:783-6.
11. 11. Elgamal AA, Van de Voorde W, Van Poppel H, Lauweryns J, Baert L. Immunohistochemical localization of prostate-specific markers within the accessory male sex glands of Cowper, Litre and Morgagni. Urology 1994;44:84-90.
12. 12. Yu H, Diamandis EP, Sutherland DJA. Immunoreactive prostate-specific antigen levels in female and male breast tumors and its association with steroid hormone receptors and patient age. Clin Biochem 1994;27:75-9.
13. 13. Diamandis EP, Yu H, Sutherland DJA. Detection of prostate-specific antigen immunoreactivity in breast tumors. Breast Cancer Res Treat 1994:32:301-10.
14. 14. Zarghami N, Grass L, Diamandis EP. Steroid hormone regulation of prostate-specific antigen gene expression in breast cancer. Br J Cancer 1997;75:579-88.
15. 15. Clements J, Mukhtar A. Glandular kallikrein and prostatic specific antigen are expressed in the human endometrium. J Clin Endocrinol Metab 1994;78;1536-9.
16. 16. Yu H, Diamandis EP. Prostate specific immunoreactivity in milk of lactating women. Clin Chem 1994:41:54-60.
17. 17. Diamandis EP, Yu H, López-Otín C. Prostate specific antigen-a new constituent of breast cyst fluid. Breast Cancer Res Treat 1996:38:259-64.
18. 18. Yu H, Diamandis EP. Prostate specific antigen immunoreactivity in amniotic fluid. Clin Chem 1995;41:204-10.
19. 19. Melegos DN, Yu H, Allen LC, Diamandis EP. Prostate-specific antigen in amniotic fluid of normal and abnormal pregnancies. Clin Biochem 1996:29:555-62.
20. 20. Schedlich LJ, Bennets BH, Morris BJ. Primary structure of a human glandular kallikrein gene. DNA 1987;6:429-37.
21. 21. Chapdelaine P, Paradis G, Tremblay RR, Dube JY. High level of expression in the prostate of a human glandular kallikrein mRNA related to a prostate-specific antigen. FEBS Lett 1988:236:205-8.
22. 22. Young CY, Andrews PE, Montgomery BT, Tindall DJ. Tissue-specific and hormonal regulation of human prostate specific glandular kallikrein. Biochemistry 1992:31:818-24.
23. 23. Mikolajczyk SD, Millar LS, Kumar A, Saedi MS. Human glandular kallikrein, hK2, shows arginine-restricted specificity and forms complexes with plasma protease inhibitors. Prostate 1998;34:44-50.
24. 24. Kumar A, Mikolajczyk SD, Goel AS, Millar LS, Saedi MS. Expression of pro form of prostate-specific antigen by mammalian cells and its conversion to mature, active form by human kallikrein 2. Cancer Res 1997:57:3111-4.
25. 25. Lövgren J, Rajakoski K, Karp M, Lundwall A, Lilja H. Activation of the zymogen form of prostate-specific antigen by human glandular kallikrein 2. Biochem Biophys Res Commun 1997:238:549-55.
26. 26. Takayama TK, Fujikawa K, Davie EW. Characterization of the precursor of prostate specific-antigen. Activation by trypsin and by human glandular kallikrein. J Biol Chem 1997;272:21582-8.
27. 27. Kumar A, Goel AS, Hill TM, Mikolajczyk SD, Millar LS, Kuus-Reichel K, et al. Expression of human glandular kallikrein, hK2 in mammalian cells. Cancer Res 1996;56:5397-402.
28. 28. Finlay JA, Evans CL, Day JR, Mikolajczyk SD, Millar LS, Kuus-Reichel K, et al. Development of monoclonal antibodies specific for human glandular kallikrein (hK2): development of a dual antibody immunoassay for hK2 with negligible prostate-specific antigen cross-reactivity. Urology 1998;51:804-9.
29. 29. Hsieh ML, Charlesworth C, Goodmanson M, Zhang S, Seay T, Klee GG, et al. Expression of human prostate-specific glandular kallikrein protein (hK2) in the breast cancer cell line T47-D. Cancer Res 1997;57:2651-6.
30. 30. Black MH, Magklara A, Obiezu C, Levesque MA, Sutherland DJA, Tindall DJ, et al. Expression of a prostate associated protein, human glandular kallikrein (hK2) in breast tumors and in normal breast secretions. Br J Cancer 1999;in press.
31. 31. Ferguson RA, Yu H, Kalyvas M, Zammit S, Diamandis EP. Ultrasensitive detection of prostate specific antigen by a time-resolved immunofluorometric assay and the Immulite immunochemiluminescent third generation assay: potential applications in prostate and breast cancers. Clin Chem 1996:42:675-84.
32. 32. Black MH, Magklara A, Obiezu C, Melegos D, Diamandis EP. Development of an ultrasensitive immunoassay for human glandular kallikrein with no cross-reactivity from prostate-specific antigen. Clin Chem 1999;45:790-9.
33. 33. Dubé JY, Tremblay RR. Biochemistry and potential roles of prostatic kallikrein hK2. Mol Urol 1997:1:279-85.
34. 34. Haagensen CD, Boduan C, Haagensen DE. Breast carcinoma, risk and detection. Philadelphia, PA: WB Saunders, 1981.
35. 35. Ciatto S, Biggeri A, Rosselli Del Turco M, Bartoli D, Iossa A. Risk of breast cancer subsequent to proven gross cystic disease. Eur J Cancer 1990:26:555-7.
36. 36. Dogliotti L, Orlandi F, Torta M, Buzzi G, Naldoni C, Mazzotti A, et al. Cations and dehydroepiandrosterone-sulfate in cyst fluid of preand menopausal patients with gross cystic disease of the breast. Evidence for the existence of subpopulations of cysts. Eur J Cancer Clin Oncol 1986:11:1301-7.
37. 37. Lai LC, Erbas H, Lennard TW, Peaston RT. Prostate-specific antigen in breast cyst fluid: possible role of prostate-specific antigen in hormone-dependent breast cancer. Int J Cancer 1996: 66:743-6.
38. 38. Filella X, Molina R, Alcover J, Menendez V, Gimenez N, Jo J, et al. Prostate-specific antigen detection by ultrasensitive assay in samples from women. Prostate 1996:29:311-6.
39. 39. Mannello F, Bocchiotti G, Bianchi G, Marcheggiani F, Gazzanelli G. Quantification of prostate-specific antigen immunoreactivity in human breast cyst fluids. Breast Cancer Res Treat 1996;38:247-52.
40. 40. Borchert GH, Yu H, Tomlinson G, Giai M, Roagna R, Ponzone R, et al. Prostate specific antigen molecular forms in breast cyst fluid and serum of women with fibrocystic breast disease. J Clin Lab Anal 1999:13:75-81.
41. 41. Furlanetto RW, DiCarlo JN. Somatomedin-C receptors and growth effects in human breast cells maintained in long-term tissue culture. Cancer Res 1984;44:2122-8.
42. 42. Zapf J, Froesch ER. Pathophysiological and clinical aspects of the insulin-like growth factors. Horm Res 1986:24:160-5.
43. 43. Wang DY, Hamed H, Mockridge CI, Fentiman IS. Radioimmunoassayable insulin-like growth factor-I in human breast cyst fluid. Eur J Cancer Clin Oncol 1989;25:867-72.